The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Primary and metastatic rhabdomyosarcoma in the breast: Neoplasms of adolescent females, a report from the Intergroup Rhabdomyosarcoma Study
D.M. Hays; S.S. Donaldson; H. Shimada; W.M. Crist; Jr. Newton W.A.; R.J. Andrassy; E. Wiener; J. Green; T. Triche; H.M. Maurer (Profiled Author: Harold Maurice Maurer)
Medical and Pediatric Oncology 1997;29(3):181-189.Abstract
The occurrence of rhabdomyosarcoma (RMS) primary in or metastatic to breast has been regarded as an uncommon event, associated with an unfavorable outcome. Records of 26 patients with diagnoses of breast RMS, either primary or secondary, entered in the Intergroup Rhabdomyosarcoma Study (IRS) (1972- 1992) were reviewed and compared with data regarding 47 similar patients in published reports. Of the 26 IRS cases, the histologic subtype was alveolar in 24, embryonal in 1, and not determined in 1. All were female with ages ranging from 11.5 to 20.2 years (median, 15.2 years; mode, 14-16 years). This compact age distribution of both primary (n = 7) and metastatic (n = 19) breast RMS was seen in previously reported series. Among the 19 cases of RMS with initial dissemination to breast, primary tumor sites were: extremity (n = 8), nasopharynx/paranasal sinuses (n = 7), and trunk (n = 4). IRS treatment was risk-based according to site and extent of disease. Four of 7 patients with primary RMS remain disease free 2.9 to 7 years post diagnosis. Among 19 patients with RMS initially metastatic to breast, including 7 in IRS clinical group IV at original diagnosis, three are disease free at 7.6, 15.7 and 17.0 years. Conclusions: primary or metastatic RMS in breast is almost confined to adolescent females having tumors with alveolar histology. Approximately one- half of the patients with primary breast disease and 15% of those with metastatic breast disease as an initial recurrence are long-term survivors.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Lynn Million; James Anderson; John Breneman; Douglas S. Hawkins; Fran Laurie; Jeff Michalski; David Rodeberg; Moody Wharam; Suzanne Wolden; Sarah S. Donaldson
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: A report from the children's oncology groupInternational Journal of Radiation Oncology Biology Physics 2011;80(2):333-338.
Lynn M. Smith; James R. Anderson; Cheryl M. CoffinMedical and Pediatric Oncology 2002;38(6):398-404.
James R. Anderson; Frederic G. Barr; Douglas S. Hawkins; David M. Parham; Stephen X. Skapek; Timothy J. TricheJournal of Clinical Oncology 2010;28(29):e587-e588.
Appears in this Document